The 5-HT2AR agonist PET ligand [11C]Cimbi-36 has higher sensitivity to serotonin receptor agonists and has been used to demonstrate that the acute subjective effects of psilocybin (specifically its active metabolite psilocin) are related to its binding at 5-HT2A receptors.

Authors

• Person: Not available Organization: Nature
  Neuroimaging in psychedelic drug development: past, present, and ...

Sources

• Neuroimaging in psychedelic drug development: past, present, and ... www.nature.com Nature via serper

Referenced by nodes (3)

• psilocybin concept
• 5-HT2A receptor concept
• 5-HT2AR concept